Preview Mode Links will not work in preview mode

Jul 28, 2020

The recent outbreak of COVID-19 has highlighted the need for fast and efficient development and production of vaccines for a whole gamut of pathogens, old and new.

Microfluidics technologies can be used to accelerate the vaccine development process in a number of ways, not least in the directed evolution of the strains...

Jul 14, 2020

In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify candidate compounds that inhibit the activity of the SARS-CoV-2 main protease, in order to develop a clinically effective antiviral.

The aptly named COVID-19 Moonshot aims to...